EDAP TMS (EDAP) entered into a EUR 36M multi-tranche credit facility with the European Investment Bank . Proceeds from the financing will be used to support the continued global expansion of the Company’s Focal One Robotic High-Intensity Focused Ultrasound platform. The funds will also accelerate the development of new clinical indications for the Company’s innovative HIFU technology. EDAP expects to draw the first tranche of EUR 11M under the Credit Facility in the fourth quarter of 2025.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on EDAP:
- EDAP TMS: Focal One Robotic HIFU featured on ‘Health Uncensored with Dr. Drew’
- EDAP TMS Focuses on Robotic HIFU Leadership in Prostate Cancer
- EDAP TMS Secures HIFU Reimbursement for Prostate Cancer in France
- EDAP TMS receives HIFU reimbursement for prostate cancer in France
- Promising Growth Trajectory and Strategic Moves Justify Buy Rating for EDAP TMS